PsyRx CNS Bio-Tech (XTAE:PSRX) Tax Expense: ₪ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:PSRX PsyRx CNS Bio-Tech Ltd XTAE:PSRX
10 GF Score
Price ₪0.73
! 1 Warning Sign
View Full Analysis

What is PsyRx CNS Bio-Tech Tax Expense?

PsyRx CNS Bio-Tech XTAE:PSRX +3.09% 10 Tax Expense is ₪ Mil as of . 20. GuruFocus rates XTAE:PSRX with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

PsyRx CNS Bio-Tech's tax expense for the six months ended in . 20 was ₪0.00 Mil.


PsyRx CNS Bio-Tech  (XTAE:PSRX) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


PsyRx CNS Bio-Tech Tax Expense Related Terms


PsyRx CNS Bio-Tech Tax Expense Historical Data

* Premium members only.

The historical data trend for PsyRx CNS Bio-Tech's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PsyRx CNS Bio-Tech Tax Expense Chart

PsyRx CNS Bio-Tech Annual Data
Trend
Tax Expense

PsyRx CNS Bio-Tech Semi-Annual Data
Tax Expense
XTAE:PSRX
10GF Score
PsyRx CNS Bio-Tech Ltd XTAE:PSRX
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PsyRx CNS Bio-Tech Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of ₪ Mil mean?
PsyRx CNS Bio-Tech (XTAE:PSRX) has a Tax Expense of ₪ Mil as of . 20. Tax expense is the amount of tax the company pays in an accounting period. View historical data on PsyRx CNS Bio-Tech and its competitors.
Is PsyRx CNS Bio-Tech's Tax Expense too high?
PsyRx CNS Bio-Tech's current Tax Expense is ₪ Mil. Overall, PsyRx CNS Bio-Tech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does PsyRx CNS Bio-Tech's Tax Expense compare to ZTS and UTHR?
PsyRx CNS Bio-Tech's Tax Expense of ₪ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on PsyRx CNS Bio-Tech and its competitors. PsyRx CNS Bio-Tech's current Tax Expense is ₪ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyRx CNS Bio-Tech stock overvalued right now?
PsyRx CNS Bio-Tech (XTAE:PSRX) has a current Tax Expense of ₪ Mil. The current Tax Expense is ₪ Mil. PsyRx CNS Bio-Tech's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For PsyRx CNS Bio-Tech (XTAE:PSRX), the current Tax Expense is ₪ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PsyRx CNS Bio-Tech Business Description

Address Arik Einstein 3, Herzliya, ISR, 4610301
PsyRx CNS Bio-Tech Ltd Formerly Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.
10GF Score

Get the complete analysis for XTAE:PSRX

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.73
Price